Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -184.27% is 22% below its 5-year average of -151.38%, around the middle of its 5-year range (-350.25%–-34.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.26% above its 12-month average of -298.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -184.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-184.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-298.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-206.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-151.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-91.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.26%
CURRENT VS 3Y AVG
+10.93%
CURRENT VS 5Y AVG
-21.72%
CURRENT VS 10Y AVG
-100.45%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
-451.94%
vs the sector median at left
IceCure Medical Ltd
Market Cap
$3.28M
Return on Invested Capital (ROIC)
-184.27%
TTM Avg
-298.45%
3Y Avg
-206.88%
5Y Avg
-151.38%
Market Cap
$3.25M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.27M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
Market Cap
$3.21M
Return on Invested Capital (ROIC)
-69.04%
TTM Avg
-69.04%
3Y Avg
-66.04%
5Y Avg
-57.92%
Market Cap
$3.40M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
Market Cap
$3.46M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.47M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49M
Return on Invested Capital (ROIC)
-45.77%
TTM Avg
-25.13%
3Y Avg
-754.36%
5Y Avg
-475.60%
Market Cap
$3.58M
Return on Invested Capital (ROIC)
-600.62%
TTM Avg
-217.41%
3Y Avg
-160.53%
5Y Avg
-160.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.28M | -184.27% | -298.45% | -206.88% | -151.38% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | -284.81% | -319.42% | -246.02% | -246.02% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -133.29% | -160.18% | -147.91% | -122.63% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | -69.04% | -69.04% | -66.04% | -57.92% |
| Moolec Science S.A. (MLEC)vs › | $3.40M | -33.50% | -18.16% | -45.78% | -36.63% |
| Evogene Ltd. (EVGN)vs › | $3.46M | -130.12% | -72.08% | -61.96% | -55.38% |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | -600.62% | -217.41% | -160.53% | -160.53% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -464.86% | -2260.77% | -1213.54% | -842.71% |
ROIC
-184.3%
ROE
-141.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -184.27% |
| 2026-03-31 | -350.25% |
| 2025-12-31 | -321.91% |
| 2025-09-30 | -316.05% |
| 2025-06-30 | -319.76% |
| 2025-03-31 | -257.09% |
| 2024-12-31 | -222.26% |
| 2024-09-30 | -141.86% |
| 2024-06-30 | -132.51% |
| 2024-03-31 | -127.80% |
| 2023-12-31 | -124.22% |
| 2023-09-30 | -106.11% |
| 2023-06-30 | -85.31% |
| 2023-03-31 | -72.68% |
| 2022-12-31 | -64.75% |
| 2022-09-30 | -100.66% |
| 2022-06-30 | -75.35% |
| 2022-03-31 | -54.52% |
| 2021-12-31 | -34.41% |
| 2021-09-30 | -51.33% |
| 2021-06-30 | -35.93% |
| 2020-12-31 | -63.48% |
| 2020-06-30 | -118.33% |
| 2020-03-31 | -133.14% |
| 2019-12-31 | -122.32% |
| 2019-09-30 | -33.92% |
| 2019-06-30 | -126.58% |
| 2019-03-31 | -31.80% |
| 2018-12-31 | -80.36% |
| 2018-09-30 | -15.96% |
| 2018-06-30 | -49.06% |
| 2018-03-31 | -12.89% |
| 2017-12-31 | -201.72% |
| 2017-09-30 | -37.15% |
| 2017-06-30 | -113.54% |
| 2017-03-31 | -34.21% |
| 2016-12-31 | -113.96% |
| 2016-09-30 | -88.52% |
| 2016-06-30 | -134.62% |
| 2016-03-31 | -106.14% |
| 2015-12-31 | -80.06% |
| 2015-09-30 | -70.53% |
| 2015-06-30 | -61.67% |
| 2015-03-31 | -64.10% |
| 2014-12-31 | -44.09% |
| 2014-09-30 | -44.62% |
| 2014-06-30 | -30.46% |
| 2014-03-31 | -22.73% |
| 2013-12-31 | -17.10% |
| 2013-09-30 | -15.05% |
| 2013-06-30 | -34.04% |
